U.S. Wireless Telecom Stock News

Trupanion (TRUP) shares are in focus after the Human Animal Bond Research Institute announced a new partnership with the pet insurer, centering on research and support for service dogs and the broader human animal bond. See our latest analysis for Trupanion. Despite the HABRI partnership highlighting Trupanion's role in supporting the human animal bond, the stock has faced selling pressure, with a 90 day share price return of 32.03% decline and a 1 year total shareholder return of 31.47%...

In recent days, Corebridge Financial has faced sector-wide pressure as concerns about private credit stability, tighter lending to private credit providers, and fund redemption limits prompted investors to reassess risk across financial companies. At the same time, Corebridge Financial increased its dividend by 4% for shareholders of record as of March 17, 2026, signaling management’s emphasis on returning capital despite heightened market scrutiny of its private credit exposure and cash...

Earlier this month, The Toro Company reported first-quarter fiscal 2026 results showing sales of US$1,036.3 million and net income of US$67.9 million, and management raised full-year 2026 net sales growth guidance to a range of 3% to 6.5%. Management attributed the stronger performance and confidence in higher guidance to robust demand for snow and ice products, contributions from recent acquisitions, and progress on cost-saving initiatives such as the AMP productivity program. Next, we’ll...

In March 2026, Par Pacific Holdings attracted increased attention as Barclays PLC raised its stake by almost one-quarter, while multiple brokerage firms maintained an “Outperform” consensus rating on the company. This combination of higher institutional ownership and supportive analyst views highlights growing institutional engagement with Par Pacific’s refining and fuel distribution footprint in Hawaii and the Rocky Mountain region. We’ll now explore how rising institutional ownership,...

RB Global (RBA) has put a new US$500 million share repurchase plan on the table, targeting up to 10,000,000 shares. The move immediately shifts attention to capital allocation and shareholder returns. See our latest analysis for RB Global. The buyback news comes after a softer period for the shares, with a 7 day share price return of 6.72% and a 90 day share price return of 5.29%. In contrast, the 3 year total shareholder return of 99.05% and 5 year total shareholder return of 91.35% indicate...

Quaker Chemical (KWR) has been drawing attention after a period of weaker share performance, with the stock down about 34% over the past month and 14% over the past 3 months. See our latest analysis for Quaker Chemical. Looking beyond the recent slump, Quaker Chemical’s 30-day share price return of 33.95% and year to date share price return of 14.76% contrast with a 1-year total shareholder return of 4.99% and a 5-year total shareholder return of 48.90%. This suggests that shorter term...

Earlier in March 2026, ProPetro Holding reported quarterly results that beat analyst expectations and showed a move back into profitability, while crude oil prices climbed sharply following renewed attacks on Middle East energy infrastructure that raised concerns about supply disruptions. This combination of stronger operating performance and a supportive commodity backdrop highlighted how closely ProPetro’s prospects are tied to both execution and broader geopolitical tensions in energy...

Nabors Industries recently reported its fourth-quarter 2025 results, posting adjusted profit of US$0.17 per share and higher operating revenue year over year, driven by stronger contributions from its International Drilling and Drilling Solutions segments. An interesting aspect of this report is how improved free cash flow generation and segment performance have encouraged analysts to revise their estimates upward and assign a more optimistic outlook for the company. Now we’ll examine how...

Recent quarterly results from Bio-Techne (TECH) came in ahead of earnings and revenue forecasts, and were followed by fresh institutional buying and portfolio additions that put renewed attention on the life sciences supplier. See our latest analysis for Bio-Techne. Despite the upbeat quarter and renewed institutional interest, the 30 day share price return of a 15.15% decline and 1 year total shareholder return of an 18.27% loss show momentum has been weak, with pressure building across both...

Recently, Boise Cascade reported quarterly earnings and revenue that came in ahead of analyst expectations, even as it faced typical seasonal softness and broader market headwinds in its building products markets. The company also highlighted progress on its Thorsby i-line expansion, disciplined operational controls, and lean channel inventories, which together point to a tighter, more efficient operating base for its engineered wood and distribution businesses. Next, we'll examine how this...

In March 2026, Revolve Group, Inc. launched Revolve Los Angeles, its first namesake fashion house, debuting a XXS–XL collection priced around US$200–US$3,500 and sold exclusively on Revolve and FWRD. The move expands Revolve’s in-house brand portfolio into higher-end, couture-influenced ready-to-wear, potentially deepening customer engagement around luxury, Los Angeles-inspired fashion. Next, we’ll examine how Revolve Los Angeles, as a higher-end in-house label, could influence Revolve...

Earlier this month, Hess Midstream LP announced that its Board authorized a share repurchase program and entered into an agreement with JPMorgan Chase Bank to buy back up to US$42 million of Class A shares, funded through its existing revolving credit facility, with repurchased shares to be cancelled and final settlement expected by March 2026. This accelerated share repurchase arrangement not only reduces the public float but also underscores management’s willingness to use balance sheet...

Why the leadership reshuffle at Playtika Holding (PLTK) matters for shareholders Playtika Holding (PLTK) is reshaping its senior ranks, with long serving President and CFO Craig Abrahams set to depart on April 1, 2026, and responsibilities shifting to existing insiders. Board chair Robert Antokol will add the President role. Senior finance leader Tae Lee will step in as acting CFO after several years overseeing corporate finance and investor relations. See our latest analysis for Playtika...

Netskope (NTSK) is back in focus after launching its Netskope One AI Security suite, alongside fresh earnings results and new healthcare integrations that together highlight how it is positioning around enterprise AI security. See our latest analysis for Netskope. Despite the launch of Netskope One AI Security and new healthcare integrations, Netskope’s short term share price return has been mixed. The 7 day share price return is 20.75% and the 90 day share price return is 51.40%, which...

InnovAge Holding (INNV) has just been upgraded to a higher Zacks rank, supported by rising earnings estimate revisions and a hammer chart pattern that points to improving sentiment and renewed attention on the stock. See our latest analysis for InnovAge Holding. At a share price of $8.39, InnovAge Holding has seen short term share price pressure, with a 7 day share price return of a 4.22% decline, alongside strong recent momentum reflected in a 90 day share price return of 51.17% and a 1 year...

In March 2026, Sensata Technologies announced its FaultBreak contactor, a next-generation high voltage switching and protection solution for electric vehicles, combining passive and resettable fuse functions to improve fault clearing, safety, and system simplicity. By merging fuse and contactor functions into a compact, resettable device that cuts component count by over half, FaultBreak aims to help automakers reduce system cost, weight, and complexity while enhancing EV safety and...

Apellis Pharmaceuticals recently added Mikael Dolsten, M.D., Ph.D., former chief scientific officer of Pfizer, to its board of directors, bringing decades of high-level research and development leadership across major global drug makers. This appointment, alongside growing analyst interest in Apellis’s key products Empaveli and Syfovre, underscores how external experts view the company’s pipeline and commercial portfolio as increasingly relevant in rare kidney disease and eye care...

Expeditors International of Washington recently reported Q4 2025 results with earnings per share of US$1.49 and revenue of US$2.86 billion, both ahead of analyst forecasts despite year-on-year declines. The board also approved a new share repurchase program of up to US$3.00 billion, highlighting management’s willingness to return substantial capital to shareholders. Next, we’ll examine how the stronger-than-expected quarterly earnings reshape Expeditors International of Washington’s...

The Morning Bull - US Market Morning Update Monday, Mar, 16 2026 US stock futures are pointing higher this morning, with contracts tied to the S&P 500 and Nasdaq up around 0.4%, as investors weigh stubborn inflation against a still resilient consumer. The PCE price index, the Federal Reserve’s preferred inflation gauge, rose 0.3% in January and core PCE climbed 0.4%, which means the cost of living is easing more slowly than the Fed’s 2% goal. At the same time, personal spending increased 0.4%...

Korn Ferry recently reported third-quarter fiscal 2026 results showing year-over-year growth in revenue to US$725.04 million and higher net income of US$65.27 million, alongside guidance for fourth-quarter fee revenue of US$730 million to US$750 million and diluted EPS of US$1.34 to US$1.40. The company also approved a 15% increase in its quarterly dividend to US$0.55 per share, signaling confidence in its cash generation while adding former Deloitte U.S. COO Pete Shimer to its board,...

Earnings update and guidance shift Sunbelt Rentals Holdings (SUNB) is back in focus after reporting third quarter results alongside a tighter full year rental revenue outlook, with investors weighing higher revenue against lower net income and the revised 2% to 3% growth range. The company reported third quarter sales of US$2,443 million and revenue of US$2,637 million. Net income for the period was US$290 million compared with US$325 million a year earlier. For the nine months to January 31,...

Earlier this week, SEC filings showed that Cactus President Joel Bender and CEO Scott Bender each sold 136,037 shares, with no offsetting insider purchases reported over the past year. These insider sales landed just as energy markets weakened on lower crude oil and natural gas prices, raising questions about how leadership actions and sector pressures intersect for Cactus’s longer-term story. Next, we will examine how this concentrated insider selling by top executives may influence...

Investors may be wondering if Navan at around US$8.90 is starting to look interesting on value, or if the recent price action is a warning sign. The stock has seen a 10% decline over the last 7 days and a 14.8% decline over the last 30 days, contributing to a 45.2% drop year to date, which can change how the market is thinking about both upside and risk. Recent coverage of Navan has focused on how the market is reassessing newer listings and higher risk names, with investors paying closer...

Wondering if FTI Consulting at around US$162.58 is fairly priced, too expensive, or offering value right now? This article walks through the key signals you can use to judge that for yourself. The stock has been under some pressure recently, with a 3.0% decline over the last week, a flat 0.1% slip over the past month, and returns of 4.5% lower year to date and 0.7% lower over the past year, even though the 5 year return sits at 18.5%. These moves sit against a backdrop of ongoing interest in...